Pawlak J - Search Results

1

Ceftaroline-heteroresistant Staphylococcus aureus.

Saravolatz SN, Martin H, Pawlak J, Johnson LB, Saravolatz LD. Saravolatz SN, et al. Among authors: pawlak j. Antimicrob Agents Chemother. 2014 Jun;58(6):3133-6. doi: 10.1128/AAC.02685-13. Epub 2014 Mar 17. Antimicrob Agents Chemother. 2014. PMID: 24637680 Free PMC article.

2

In-vitro activity of 29 antimicrobial agents against penicillin-resistant and -intermediate isolates of Streptococcus pneumoniae.

Manzor O, Pawlak J, Saravolatz L. Manzor O, et al. Among authors: pawlak j. J Antimicrob Chemother. 1999 Jan;43(1):31-6. doi: 10.1093/jac/43.1.31. J Antimicrob Chemother. 1999. PMID: 10381098

3

Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae.

Saravolatz L, Manzor O, Check C, Pawlak J, Belian B. Saravolatz L, et al. Among authors: pawlak j. J Antimicrob Chemother. 2001 Jun;47(6):875-7. doi: 10.1093/jac/47.6.875. J Antimicrob Chemother. 2001. PMID: 11389122

4

Antimicrobial activity of BMS 284756, a novel des-fluoro (6) quinolone and seven fluoroquinolones against Streptococcus pneumoniae.

Saravolatz L, Manzor O, Pawlak J, Belian B. Saravolatz L, et al. Among authors: pawlak j. Clin Microbiol Infect. 2001 Oct;7(10):572-3. Clin Microbiol Infect. 2001. PMID: 11683802 Free article. No abstract available.

5

Broad-range bacterial polymerase chain reaction for early detection of bacterial meningitis.

Saravolatz LD, Manzor O, VanderVelde N, Pawlak J, Belian B. Saravolatz LD, et al. Among authors: pawlak j. Clin Infect Dis. 2003 Jan 1;36(1):40-5. doi: 10.1086/345438. Epub 2002 Dec 12. Clin Infect Dis. 2003. PMID: 12491200

6

Changing epidemiology of community-onset methicillin-resistant Staphylococcus aureus bacteremia.

Johnson LB, Bhan A, Pawlak J, Manzor O, Saravolatz LD. Johnson LB, et al. Among authors: pawlak j. Infect Control Hosp Epidemiol. 2003 Jun;24(6):431-5. doi: 10.1086/502227. Infect Control Hosp Epidemiol. 2003. PMID: 12828320

7

Antimicrobial activity and a comparison of published pharmacodynamics of gemifloxacin and eight fluoroquinolones against Streptococcus pneumoniae.

Saravolatz L, Manzor O, Pawlak J, Belian B. Saravolatz L, et al. Among authors: pawlak j. Int J Antimicrob Agents. 2005 Jul;26(1):81-4. doi: 10.1016/j.ijantimicag.2005.03.004. Int J Antimicrob Agents. 2005. PMID: 15951159

8

Clinical and laboratory features of community-associated methicillin-resistant Staphylococcus aureus: is it really new?

Johnson LB, Saeed S, Pawlak J, Manzor O, Saravolatz LD. Johnson LB, et al. Among authors: pawlak j. Infect Control Hosp Epidemiol. 2006 Feb;27(2):133-8. doi: 10.1086/500621. Epub 2006 Feb 8. Infect Control Hosp Epidemiol. 2006. PMID: 16465629

9

Community-associated methicillin-resistant Staphylococcus aureus causing chronic pneumonia.

Enayet I, Nazeri A, Johnson LB, Riederer K, Pawlak J, Saravolatz LD. Enayet I, et al. Among authors: pawlak j. Clin Infect Dis. 2006 Apr 1;42(7):e57-60. doi: 10.1086/501125. Epub 2006 Feb 28. Clin Infect Dis. 2006. PMID: 16511747

10

Emergence of community-associated methicillin-resistant Staphylococcus aureus infection among patients with end-stage renal disease.

Johnson LB, Venugopal AA, Pawlak J, Saravolatz LD. Johnson LB, et al. Among authors: pawlak j. Infect Control Hosp Epidemiol. 2006 Oct;27(10):1057-62. doi: 10.1086/507958. Epub 2006 Sep 18. Infect Control Hosp Epidemiol. 2006. PMID: 17006812

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

365 results

Search Page

Filters